180 related articles for article (PubMed ID: 9814685)
1. Anti beta2-glycoprotein I antibodies: clinical significance.
Tincani A; Spatola L; Cinquini M; Cattaneo R; Meroni P; Balestrieri G
Lupus; 1998; 7 Suppl 2():S107-9. PubMed ID: 9814685
[TBL] [Abstract][Full Text] [Related]
2. Beta2-glycoprotein I: target antigen for 'antiphospholipid' antibodies. Immunological and molecular aspects.
Sheng Y; Kandiah DA; Krilis SA
Lupus; 1998; 7 Suppl 2():S5-9. PubMed ID: 9814663
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulants.
Arnout J; Vermylen J
Lupus; 1998; 7 Suppl 2():S23-8. PubMed ID: 9814667
[TBL] [Abstract][Full Text] [Related]
4. Antiprothrombin antibody: why do we need more assays?
Atsumi T; Koike T
Lupus; 2010 Apr; 19(4):436-9. PubMed ID: 20353984
[TBL] [Abstract][Full Text] [Related]
5. Anticardiolipin antibody and anti-beta 2 glycoprotein I antibody assays.
Raby A; Moffat K; Crowther M
Methods Mol Biol; 2013; 992():387-405. PubMed ID: 23546732
[TBL] [Abstract][Full Text] [Related]
6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
7. Anticardiolipin and anti-beta-2-glycoprotein I antibodies.
Marai I; Tincani A; Balestrieri G; Shoenfeld Y
Autoimmunity; 2005 Feb; 38(1):33-8. PubMed ID: 15804703
[TBL] [Abstract][Full Text] [Related]
8. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
9. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
[TBL] [Abstract][Full Text] [Related]
11. Anti-beta2-glycoprotein I antibodies.
Tsutsumi A; Ichikawa K; Matsuura E; Koike T
Lupus; 1998; 7 Suppl 2():S98-102. PubMed ID: 9814683
[TBL] [Abstract][Full Text] [Related]
12. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
Arnoux D; Boutière B; Sanmarco M
Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
[TBL] [Abstract][Full Text] [Related]
13. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of anti-beta2 glycoprotein I and anticardiolipin assays for clinical manifestations of the antiphospholipid syndrome.
Santiago M; Martinelli R; Reis MG; Reis EA; Ko A; Fontes RD; Silva MP; Nascimento EG; de Jesus R; Pierangeli S; Espinola R; Gharavi A
Clin Rheumatol; 2004 Dec; 23(6):485-9. PubMed ID: 15801067
[TBL] [Abstract][Full Text] [Related]
16. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
[TBL] [Abstract][Full Text] [Related]
17. Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis.
Li R; Daguzan M; Vandermijnsbrugge F; Gyling M; Cantinieaux B
Acta Clin Belg; 2014 Dec; 69(6):433-8. PubMed ID: 25103595
[TBL] [Abstract][Full Text] [Related]
18. [Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases.
Biasiolo A; Rampazzo P; Brocco T; Barbero F; Rosato A; Pengo V
Lupus; 1999; 8(2):121-6. PubMed ID: 10192506
[TBL] [Abstract][Full Text] [Related]
19. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
20. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
